A carregar...
The role of personalized medicine in metastatic colorectal cancer: an evolving landscape
Advances in the treatment of metastatic colorectal cancer have led to an improvement in survival from 12 months with fluorouracil monotherapy to approximately 2 years. This is partly as a result of the addition of irinotecan and oxaliplatin, but is also due to the use of monoclonal antibodies agains...
Na minha lista:
Main Authors: | , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
SAGE Publications
2013
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3756633/ https://ncbi.nlm.nih.gov/pubmed/24003339 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X13491797 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|